|
Worrall, N K; Misko, T P; Botney, M D et al. (1999) Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection. Ann Thorac Surg 67:716-22
|
|
Worrall, N K; Pyo, R T; Botney, M D et al. (1997) Inflammatory cell-derived NO modulates cardiac allograft contractile and electrophysiological function. Am J Physiol 273:H28-37
|
|
Worrall, N K; Chang, K; LeJeune, W S et al. (1997) TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 273:H2565-74
|
|
Worrall, N K; Boasquevisque, C H; Botney, M D et al. (1997) Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 63:1095-101
|
|
Worrall, N K; Misko, T P; Sullivan, P M et al. (1996) Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation 61:324-8
|
|
Worrall, N K; Misko, T P; Sullivan, P M et al. (1996) Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. Ann Thorac Surg 62:378-85
|
|
Worrall, N K; Chang, K; Suau, G M et al. (1996) Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection. Circ Res 78:769-79
|
|
Worrall, N K; Lazenby, W D; Misko, T P et al. (1995) Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 181:63-70
|
